Creating Red Light-Switchable Protein Dimerization Systems as Genetically Encoded Actuators with High Specificity

Zhimin Huang, Zengpeng Li, Xiao Zhang, Shoukai Kang, Runze Dong, Lijun Sun, Xiaonan Fu, David Vaisar, Kurumi Watanabe, Liangcai GuACS 2020 · DOI

TL;DR

Researchers have developed a new method, COMBINES-LID, to create highly specific red light-controlled protein dimerization systems. These systems, called nanoReD, use small antibody fragments (nanobodies) and a bacterial photoreceptor to enable precise control of gene expression with minimal activity in the dark, making them promising for therapeutic applications.

What Problem Does This Paper Address?

Optogenetics, the use of light to control biological processes, holds immense promise for applications like cell and gene therapies. A key tool in this field is light-induced protein dimerization (LID), which allows for non-invasive control of molecular proximity. However, existing LID systems that respond to red light (crucial for deep-tissue penetration in mammals) often rely on complex, naturally occurring protein partners. These systems can suffer from significant "dark activity" (unwanted activation in the absence of light) and suboptimal performance in mammalian cells, limiting their clinical utility. The authors aim to overcome these limitations by developing a more efficient and generalizable method to engineer LID systems with high specificity and low dark activity, specifically for red light activation.

Methods

The core innovation is the COMBINES-LID (combinatorial binders-enabled selection of LID) method, a two-step screening process designed to identify highly specific light-induced dimerization binders.

  1. Phage Display (In Vitro Selection): A large library of synthetic nanobodies (small antibody fragments) was screened using phage display. The goal was to enrich for nanobodies that specifically bind to the light-activated form of a truncated bacterial phytochrome (DrBphP) while having minimal affinity for its dark form. This was achieved through a clever column chromatography setup that sequentially exposed the nanobody library to the dark and light forms of DrBphP, selecting for light-form specific binders.
  2. Yeast Two-Hybrid (Y2H) Screening (Cell-Based Selection): Nanobodies enriched from the phage display were then introduced into a yeast two-hybrid system. This allowed for the selection of binders that not only bind specifically to the light-activated DrBphP but also mediate functional protein-protein interactions in vivo within a cellular context.

The authors also employed:

  • Analytical Size-Exclusion Chromatography (SEC): To confirm the formation of DrBphP-nanobody complexes.
  • Isothermal Titration Calorimetry (ITC): To study the thermodynamics of nanobody binding to DrBphP.
  • Bio-Layer Interferometry (BLI): To measure the kinetics of nanobody binding.
  • Mammalian Two-Hybrid (M2H) Assay: To assess the in vivo activity and specificity of the engineered LID systems in mammalian cells (HEK293T).
  • Fluorescence Imaging (GFP Expression): To visualize red light-induced gene expression in mammalian cells.
  • Bioluminescence Imaging (Luciferase Expression): To demonstrate in vivo gene activation in mice.

Datasets

The paper does not explicitly mention or introduce new benchmark datasets for training or evaluation. Instead, it utilizes a synthetic combinatorial nanobody library (estimated diversity of 1.23 to 7.14 × 10^9) generated in previous work. The performance of the engineered LID systems is evaluated using reporter gene assays (luciferase and GFP) in cell cultures and in vivo models.

Key Insights and Ideas

  • De Novo Engineering of LID is Feasible and Effective: The COMBINES-LID method demonstrates that it's possible to engineer highly specific LID systems from scratch using a combination of in vitro and cell-based screening, rather than relying solely on naturally occurring, often suboptimal, protein pairs.
  • Nanobodies as Versatile LID Binders: The study highlights the potential of nanobodies as small, robust, and highly specific binders for optogenetic applications. Their small size and ease of engineering are significant advantages.
  • DrBphP Module is a Promising Photosensor: The use of a truncated bacterial phytochrome (DrBphP) as the photosensory module, which utilizes the endogenous mammalian chromophore biliverdin, simplifies the system and avoids the need for exogenous chromophore administration.
  • Low Dark Activity is Achievable: The engineered nanoReD systems exhibit significantly reduced dark activity compared to previous BphP-based LIDs, a critical factor for precise biological control.
  • Thermodynamics of Binding Matters for Specificity: The ITC data suggests that the binding mechanism of LDB-3 to the dark form of DrBphP, potentially involving dimer dissociation and endothermic processes, contributes to its low dark activity.

Key Results

  • The COMBINES-LID method successfully identified two nanobody-based LID systems (nanoReD1 and nanoReD2, using LDB-3 and LDB-14 respectively) that are highly specific for the light-activated form of DrBphP.
  • In mammalian cells (HEK293T), these nanoReD systems showed low dark activity and high induction specificity, with light-induced luciferase expression increasing by ~19.5-fold (LDB-3) and ~19.1-fold (LDB-14) compared to dark conditions.
  • In situ GFP expression assays in HEK293T cells showed ~44-fold (LDB-3) and ~39-fold (LDB-14) increases in fluorescence upon red light illumination.
  • In vivo studies in mice demonstrated ~25-fold average increase of bioluminescence upon red light activation, confirming the system's functionality in a living organism.
  • The engineered LID systems utilize the endogenous mammalian chromophore biliverdin, eliminating the need for external supplementation.

Limitations and Future Work

  • Protein Stability: While LDB-3 and LDB-14 showed good performance, other nanobody candidates identified in the screen had significantly decreased levels of full-length proteins in mammalian cells, suggesting potential stability issues that need further investigation.
  • Temporal Resolution: While LDB-3's fast dissociation kinetics suggest potential for higher temporal resolution, this was not extensively explored or quantified as a primary result.
  • Broader Applications: The current study focused on gene expression control. The authors suggest that these systems could be extended to control other cellular processes, such as the spatiotemporal activation of chimeric antigen receptor T (CAR-T) cells.
  • Orthogonality: The paper mentions the potential for creating orthogonal LID systems with diverse optical and structural properties, implying future work could involve developing systems responsive to different wavelengths or using different photosensor modules.
  • In Vivo Chromophore Availability: While biliverdin is endogenous, its concentration and availability in specific tissues might influence system performance, which could be a factor for future optimization.

Summary updated

Abstract

Protein dimerization systems controlled by red light with increased tissue penetration depth are a highly needed tool for clinical applications such as cell and gene therapies. However, mammalian applications of existing red light-induced dimerization systems are hampered by limitations of their two components: a photosensory protein (or photoreceptor) which often requires a mammalian exogenous chromophore and a naturally occurring photoreceptor binding protein typically having a complex structure and nonideal binding properties. Here, we introduce an efficient, generalizable method (COMBINES-LID) for creating highly specific, reversible light-induced heterodimerization systems independent of any existing binders to a photoreceptor. It involves a two-step binder screen (phage display and yeast two-hybrid) of a combinatorial nanobody library to obtain binders that selectively engage a light-activated form of a photoswitchable protein or domain not the dark form. Proof-of-principle was provided by engineering nanobody-based, red light-induced dimerization (nanoReD) systems comprising a truncated bacterial phytochrome sensory module using a mammalian endogenous chromophore, biliverdin, and light-form specific nanobodies. Selected nanoReD systems were biochemically characterized, exhibiting low dark activity and high induction specificity, and further demonstrated for the reversible control of protein translocation and activation of gene expression in mice. Overall, COMBINES-LID opens new opportunities for creating genetically encoded actuators for the optical manipulation of biological processes.
BibTeX
@inproceedings{huang2020creating,
  author = {Zhimin Huang and Zengpeng Li and Xiao Zhang and Shoukai Kang and Runze Dong and Lijun Sun and Xiaonan Fu and David Vaisar and Kurumi Watanabe and Liangcai Gu},
  title = {{Creating Red Light-Switchable Protein Dimerization Systems as Genetically Encoded Actuators with High Specificity}},
  booktitle = {ACS},
  year = {2020},
  doi = {10.1021/acssynbio.0c00397},
}

Loading related content...

Figure